| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |